The aim of the current study was to assess the rate of detection over a 5-year period and the imaging features of MRI-detected pure noncalcified DCIS among Israeli BRCA1/BRCA2 PSV carriers who attend a high-risk clinic in a single medical center between 2015 and 2020 and to compare the incidence of noncalcified DCIS by mutated gene. Here, BRCA2 is linked to ductal breast carcinoma in situ.